Tg Therapeutics (TGTX) Capital Expenditures Growth (5y) (2017 - 2026)
Tg Therapeutics (TGTX) Capital Expenditures Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.31% |
| Dec 31, 2025 | -15.44% |
| Sep 30, 2025 | -2.11% |
| Jun 30, 2025 | -1.37% |
| Mar 31, 2025 | -18.14% |
| Dec 31, 2024 | -9.19% |
| Sep 30, 2024 | -18.07% |
| Dec 31, 2022 | -55.08% |
| Sep 30, 2022 | 15.15% |
| Dec 31, 2021 | 122.20% |
| Sep 30, 2021 | 72.28% |
| Jun 30, 2021 | 63.76% |
| Mar 31, 2021 | 70.82% |
| Dec 31, 2020 | 61.92% |
| Sep 30, 2020 | 17.99% |
| Jun 30, 2020 | 27.42% |
| Mar 31, 2020 | 58.11% |
| Dec 31, 2019 | 19.30% |
| Sep 30, 2019 | 117.58% |
| Mar 31, 2019 | 34.63% |